Try the new FT.com

    Search for Sanofi and
    1. February 8, 2017

      Sanofi points to lower profit for 2017

      French drugmaker Sanofi said on Wednesday that profits for 2017 would be flat or slightly lower as it looks to...

    2. Fast FT

      February 8, 2017

      Sanofi reports strong Q4 but Venezuela slowdown weighs on annual sales

      French pharmaceutical company Sanofi said on Wednesday that company sales rose 3.3 per cent in the fourth quarter of...

    Special Reports

    1. FT Health: Vaccines

      In today’s connected world, where outbreaks of infectious disease can spread faster th...
    2. Health: Emerging Markets

      From the rising scourge of diabetes to the Ebola epidemic, responses around the world ...
    Search more Special Reports on this topic.

    1. January 18, 2017

      Drug companies pledge to improve emerging markets cancer care

      More than 20 of the world’s leading drug companies have pledged to work together to treat cancer and other...

    2. January 12, 2017

      Sanofi confident it can overturn Praluent patent ruling

      Under pressure to deliver a new blockbuster medicine, Sanofi, France’s biggest drugmaker, bet big on a new class of...

    3. January 6, 2017

      Regeneron shares tumble as US court blocks cholesterol drug

      Investors wiped more than $2bn from the market value of Regeneron, the New York-based biotech group, after a court took...

    4. December 14, 2016

      Sanofi in talks to buy biotech Actelion as J&J bows out

      Sanofi, the French drugmaker, is in talks to buy Actelion, Europe’s largest biotech company, in a deal potentially...

    5. December 14, 2016

      Actelion: PAH, humbug

      Actelion is unusual among pharma makers. This Swiss company produces a profitable drug for a rare disease , and has...

    6. Fast FT

      December 14, 2016

      Actelion shares drop 8% after J&J pulls out of merger talks

      Actelion has slumped to the bottom of Europe’s major stock index this morning after Johnson & Johnson abruptly ended...

    7. Fast FT

      December 14, 2016

      Sanofi in talks with Actelion after J&J abandons negotiations

      Sanofi, the French drug maker, is in talks with Actelion to acquire Europe’s largest biotech company in a deal that...

    8. Fast FT

      December 7, 2016

      Trump vows to bring down drug prices, biotech stocks tumble

      Investors who have been piling into biotechnology stocks were dealt a rude reality check on Wednesday. Having rallied...

    9. November 15, 2016

      Big pharma warns drug price pressure not over under Trump

      Pressure on drug prices is unlikely to dissipate under a Donald Trump presidency, senior pharmaceuticals executives...

    10. October 28, 2016

      Sanofi raises guidance on strong sales of MS treatments

      French drugmaker Sanofi on Friday posted a strong sales comeback for the third quarter, after losing out in the race to...

    11. Fast FT

      October 28, 2016

      Sanofi raises full year guidance after 'solid' momentum in Q3

      Sales at European drugmakers Sanofi and Novo Nordisk increased in the third quarter as the companies overcame mounting...

    12. September 11, 2016

      Dechra confident of winning best in show among the rare breeds

      Dechra Pharmaceuticals is like one of the rarer breeds of pets it caters to. Beyond a small group of devotees willing...

    13. September 9, 2016

      The twisted logic of negative interest rates

      Business history, of a sort, was made this week. Sanofi, the French pharmaceutical company that makes blood thinner...

    14. September 7, 2016

      Negative-yielding bonds: Why buy them? Why sell them?

      This week two public companies took free euros offered to them by investors, when they became the first to sell bonds...

    15. September 7, 2016

      Henkel/Sanofi: the positives of negatives

      Usually, when money is lent at below-zero rates, “what on Earth are you thinking” is shouted at the lender. On Tuesday,...

    16. September 7, 2016

      Takeda signals global ambitions with dengue vaccine trial

      Takeda, the largest Japanese drug group, has begun an extensive clinical trial of a vaccine against dengue, a...

    17. September 6, 2016

      Henkel and Sanofi set new milestone with negative yielding bonds

      A fresh milestone in the world of negative interest rates was reached on Tuesday, when Henkel and Sanofi became the...

    18. Fast FT

      September 6, 2016

      Henkel and Sanofi sell first negative yielding euro corporate bonds

      We have the first ever negative yielding euro corporate bonds sold by non-state owned companies. German consumer goods...

    19. August 22, 2016

      Pfizer makes $14bn bet on cancer drugmaker Medivation

      Pfizer unveiled its biggest takeover of a cancer company in its 167-year history on Monday — the $14bn acquisition of...

    20. August 22, 2016

      Pfizer/Medivation: combination therapy

      There is a grim symmetry between the challenges pharmaceutical companies face and the treatments they sell. Both are...

    21. Fast FT

      July 29, 2016

      Sanofi Q2 profits fall as sales of Lantus insulin suffer

      Sales and profits at Sanofi, the French drugmaker currently in pursuit of US cancer drug developer Medivation, dropped...

    22. July 6, 2016

      Medivation: scarcity value

      One must be a careful about criticising big pharma companies for splashing the cash on smaller, essentially one-product...

    23. July 6, 2016

      Medivation confident drugs pipeline will win over suitors

      After two years of furious dealmaking in the pharmaceuticals industry, large drugmakers have started to complain there...

    24. July 5, 2016

      Medivation agrees to $10bn takeover talks

      Medivation, the US biotech company, has agreed to hold talks about a $10bn sale with large global pharmaceutical groups...

    25. Fast FT

      July 5, 2016

      Medivation agrees to $10bn sale talks with Sanofi

      US biotech company Medivation has agreed to hold talks with Sanofi, France’s largest pharma group, about a potential...

    26. June 2, 2016

      M&A back on the table as ‘big pharma’ targets smaller rivals

      After a start to the year marred by an accounting scandal at Valeant, the collapse of Pfizer’s $160bn merger with...

    27. May 25, 2016

      Sanofi seeks to oust entire Medivation board

      Pharmaceuticals group Sanofi is trying to ram through its $9.3bn proposed takeover offer of Medivation by launching a...

    28. Fast FT

      May 25, 2016

      Sanofi seeks to replace Medivation's board in sale tussle

      French drugmaker Sanofi is seeking to replace the whole of Medivation’s board. Sanofi, which has threatened to go...

    29. May 19, 2016

      Pull together to prevent a superbug apocalypse

      Jim O’Neill, UK Treasury minister and former Goldman Sachs economist, has focused the world’s attention on...

    30. May 5, 2016

      Sanofi threatens to go hostile in $9.3bn pursuit of Medivation

      Sanofi has threatened to oust the board of Medivation if the US biotech company continues to resist its $9.3bn takeover...

    31. Fast FT

      May 5, 2016

      Sanofi threatens to go hostile in Medivation battle

      French drugmaker Sanofi has been sounding out shareholders in Medivation, the US pharmaceuticals group behind the...

    32. Fast FT

      May 4, 2016

      Private equity closes in on $7.5bn deal for MultiPlan

      Maurice “Hank” Greenberg, the 90-year-old former chief executive of AIG, is close to possibly tripling a $1.4bn...

    33. April 29, 2016

      M&A: back with a bang

      Consider it an M&A explosion that even Jack Lew, US Treasury secretary, could love. Out of the ether, $60bn worth of...

    34. Fast FT

      April 29, 2016

      Medivation rejects Sanofi's $9.3bn takeover offer

      Medivation has rejected an unsolicited $9.3bn takeover proposal from Sanofi of France as analysts predicted that...

    35. April 29, 2016

      AstraZeneca cuts costs for shift to cancer drugs

      AstraZeneca has launched a $1.1bn cost-cutting plan to accelerate its shift from mass-market primary care products to a...

    36. April 28, 2016

      Three pharma deals worth $45bn reignite M&A boom

      A trio of deals worth a combined $45bn breathed fresh life into the healthcare mergers and acquisitions boom on...

    37. April 28, 2016

      AbbVie joins wave of pharma moves with Stemcentrx deal

      AbbVie has agreed to buy Stemcentrx, a biotech company focused on cancer, in a deal worth up to $10bn, making it the...

    38. April 28, 2016

      Sanofi makes $9.3bn unsolicited cash offer for Medivation

      Sanofi, France’s largest pharma group, unveiled on Thursday an unsolicited $9.3bn bid to buy US biotech company...

    Search for Sanofi and

    RELATED VIDEOS

    Videos from FT.com that closely match this topic

    1. Lex discusses the turmoil at the French drugmaker...
      Wed Oct 29 17:27:09 GMT 2014

      Lex discusses the turmoil at the French drugmaker